Join us for an inspiring and insightful conversation during Women's History Month as we speak with Dr. Feyruz Rassool, Co-Director of the Experimental Therapeutics Program at the University of Maryland Comprehensive Cancer Center in Baltimore and a pioneer in DNA damage repair. We will delve into Dr. Rassool's remarkable life and career, including the challenges she has faced in a male-dominated field. We will hear about her experiences with diversity growing up overseas and learn how she has progressed through those challenges…

Join New Vertical Technologies for a lunch time business networking event and a discussion on AI and your business.  Food and drinks will be available to order.  This will be at Cult Classic Brewing on Kent Island.

This interactive session is designed specifically for you, the remarkable women who are shaping the future of business at every level. We’ll be delving into practices of self-reflection, exploring how they can empower you to become an even more effective leader, and fostering an open discussion where we can all learn from each other’s experiences. Whether you’re a seasoned CEO or a rising star, there’s always space for growth, and together, we can unlock our full potential. So, get ready to share…

The Master’s in Health Informatics and Data Science program at Georgetown University is designed to help you develop core competencies in data science, health-related data, predictive analytics, machine learning (ML), Artificial Intelligence (AI), and other advanced technologies. Through the program, you will be prepared to successfully take on a wide range of opportunities in healthcare organizations and related industries including, health technology developers, device manufacturers, pharma/biotech, academic medical centers, and management consulting firms. We will help our students build critical skills for this growing…

Register to attend a free NIH webinar. Attendees will learn about a new family of Proteolysis Targeting Chimeras (PROTACS) that selectively target Proviral Integration for the Moloney murine leukemia virus (PIM) kinases which have roles in cancer development and mediating resistance to radio and chemotherapy; and is overexpressed in multiple cancers. Several small molecule PIM kinase inhibitors have had minimal effect in suppressing cancer phenotypes due to the PIM kinase inhibitors promoting intrinsic resistance. By contrast, these PIM targeted PROTACs…